Research AssociateUniversity of WaterlooWaterloo, Ontario, Canada
OC 24.1 - Effect of the type of F9 mutation on the pharmacokinetic profile of patients with hemophilia B treated with extended half-life FIX concentrates.
Sunday, June 25, 202314:45 – 15:00 ET
OC 24.2 - Estimated Factor VIII Activity Levels at the Time of Bleeding Events in Individuals with Hemophilia A without Inhibitors
Sunday, June 25, 202315:00 – 15:15 ET
PB0175 - Impact of reagent on the estimation of Eloctate and Adynovate pharmacokinetic (PK) parameters?
Sunday, June 25, 202318:30 – 19:30 ET
